Table 2. Fields expected to involve biochips. Type of diagnosis Test and measurement items Effect Diagnostic technology Diagnosis of disease risk Oral mucosa, blood Polymorphism, protein ...
TORONTO, May 16, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge ...
In recent years, the measurement of multiple proteins as disease signatures or biomarkers from patient samples has risen rapidly as an enabling tool for the pharmaceutical and diagnostics industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback